Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials01:16

Clinical Trials

7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.5K
Study Design in Statistics01:15

Study Design in Statistics

8.4K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.4K
Crossover Experiments01:16

Crossover Experiments

3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute cerebral infarction caused by severe anaphylactic shock: A case report.

Journal of anesthesia and translational medicine·2026
Same author

Border-Associated Macrophages in CNS Health and Disease: A Comprehensive Review of Ontogeny, Heterogeneity, and Functional Plasticity at Neural Interfaces.

ASN neuro·2026
Same author

Baicalein activates the type I interferon signaling pathway to inhibit infectious bronchitis virus infection.

Poultry science·2026
Same author

Stabilizing O3-type layered oxide cathodes <i>via</i> dual-site co-doping for long-life sodium-ion batteries.

Chemical science·2026
Same author

LlR3MYB-mediated flavonoid biosynthesis confers cold stress tolerance in <i>Lilium lancifolium</i> through the LlDREB-LlCHS2 regulatory cascade.

Horticulture research·2026
Same author

Association of Umbilical Cord Blood P-Selectin and PTX3 Levels with Early-Onset Sepsis in Preterm Infants with Premature Rupture of Membranes.

International journal of general medicine·2026

Related Experiment Video

Updated: Sep 9, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials.

Yingjie Qiu1,2, Mingyue Li1

  • 1Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Statistical Methods in Medical Research
|September 5, 2025
PubMed
Summary

Backfill cohorts in Phase I trials improve safety and efficiency for novel cancer drugs. This Bayesian design enhances optimal dose selection and reduces patient exposure to ineffective treatments.

Keywords:
Backfilladaptive designsdose optimizationproject optimusrisk-benefit trade-off

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Related Experiment Videos

Last Updated: Sep 9, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Area of Science:

  • Clinical Pharmacology
  • Biostatistics
  • Oncology Drug Development

Background:

  • Phase I clinical trials are crucial for evaluating novel cancer therapeutics, including targeted therapies and immunotherapies.
  • The U.S. Food and Drug Administration's Project Optimus guidance (August 2024) highlights the importance of dose optimization.
  • Traditional trial designs may not adequately capture dose-response complexities for novel agents where efficacy may not correlate with dose.

Purpose of the Study:

  • To introduce a Bayesian design framework for integrating backfill cohorts into Phase I clinical trials.
  • To enhance the assessment of safety and efficacy for novel cancer treatments.
  • To optimize dose selection while minimizing patient risk and trial duration.

Main Methods:

  • Development of a robust Bayesian design framework for dose-finding studies.
  • Borrowing information across dose levels without strict parametric assumptions on dose-response relationships.
  • Joint evaluation of toxicity and efficacy, addressing challenges of delayed outcomes.

Main Results:

  • The proposed design generates valuable data for later-stage studies.
  • Improved accuracy in selecting the optimal dose for novel cancer therapies.
  • Enhanced patient safety through reduced administration of subtherapeutic doses.

Conclusions:

  • The Bayesian backfill design offers a superior approach for Phase I trials of novel cancer drugs.
  • This framework effectively balances dose exploration with patient safety and trial efficiency.
  • Simulation studies confirm the design's advantages in various realistic clinical trial settings.